Fondazione Policlinico Universitaro A. Gemelli IRCCS
Rome, Italy
NCT Number: NCT06202144
The optimal noninvasive respiratory support for acute hypoxemic respiratory failure is debated. Recent preliminary data indicate that both pressure-support noninvasive ventilation (NIV) and continuous-positive airway pressure (CPAP) may be of benefit. While often applied interchangeably in clinical practice, NIV and CPAP have different effects on the inspiratory effort, which is the major determinant of self-inflicted lung injury. Also, inspiratory effort widely varies among individuals.
The purpose of this study is to assess the physiological effects of a noninvasive respiratory support approach guided by inspiratory effort, as compared to CPAP and NIV, in patients with moderate-to-severe acute hypoxemic respiratory failure.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Rome, Italy
Patients with acute hypoxemic respiratory failure will undergo a decremental pressure-support trial during helmet noninvasive support. The following pressure-support settings will be applied sequentially, with positive end-expiratory pressure kept constant and equal to 10-12 cmH2O: 20 cmH2O, 16 cmH2O, 12 cmH2O, 8 cmH2O and high-flow-driven CPAP. Inspiratory effort will be monitored during the trial through esophageal manometry. The personalized setting of noninvasive support will be defined as the minimal pressure-support level capable of generating inspiratory effort between 5 and 10 cmH2O.
Personalized noninvasive support will be then compared to conventionally-set NIV and CPAP in a randomized cross-over trial.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Noninvasive respiratory support delivered through a helmet
Time frame: 1 hour
Tidal volume size, assessed with electrical impedance tomography
Time frame: 1 hour
The positive inspiratory swing in transpulmonary pressure, calculated as airway pressure minus esophageal pressure
Time frame: 1 hour
Inspiratory effort, defined as the negative deflection in esophageal pressure
Time frame: 1 hour
Respiratory rate per minute
Time frame: 1 hour
PaO2/FiO2 ratio
Time frame: 1 hour
Simplified esophageal pressure pressure-time product
Time frame: 1 hour
Minute ventilation (assessed with electrical impedance tomography) normalized to PaCO2
Time frame: 1 hour
Tidal volume distribution in the four lung regions of interest (ventral, mid-ventral, mid-dorsal and dorsal), assessed with electrical impedance tomography
Time frame: 1 hour
End-expiratory lung impedance, assessed with electrical impedance tomography
Time frame: 1 hour
Pendelluft, assessed with electrical impedance tomography and expressed in % of tidal volume size
Time frame: 1 hour
Defined as the ration of tidal volume to transpulmonary driving pressure
Time frame: 1 hour
Dyspnea, defined through a visual analog scale ((ranging from 0 to 10, with representing most severe dyspnea)
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Other
Physiological Effects of Personalized Noninvasive Support in Acute Hypoxemic Respiratory Failure
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06574659
Acute Hypoxic Respiratory Failure
Chengdu, Sichuan, China
View Trial DetailsNCT06490523
Acute Hypoxic Respiratory Failure
Barcelona, Catalonia, Spain
View Trial DetailsNCT06224010
ARDS, Human, Acute Hypoxic Respiratory Failure
Turin, Italy
View Trial DetailsNCT06501118
Acute Hypoxemic Respiratory Failure, Acute Hypoxic Respiratory Failure
Aurora, Colorado, United States
View Trial Details